Cardeon was founded in 2018 by Dr. Masoud Khayyami who received his PhD in Pure and applied biochemistry from the University of Lund, Sweden.


Dr. Khayyami has been successfully investing in, operating and growing early-mid stage Scandinavian Life Science companies since 2011.

To date, Cardeon has made 11 investments. The team has taken several of them to the public markets.